article · RSC Advances
findings suggest that F3 and F4 possess acceptable ADMET properties, supporting their potential as promising drug candidates. Overall, the results indicate that these functionalized xanthene-hydrazone derivatives represent a promising foundation for the development of novel vasorelaxant agents.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1039/d6ra01067a
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.